{"id":"https://openalex.org/W4407977004","doi":"https://doi.org/10.1016/j.jtct.2025.01.053","title":"Phase II Single Center Prospective Study of Ruxolitinib in Addition to Standard Graft Versus Host Disease Prophylaxis in Patients with Myelofibrosis Demonstrates Encouraging Outcomes.","display_name":"Phase II Single Center Prospective Study of Ruxolitinib in Addition to Standard Graft Versus Host Disease Prophylaxis in Patients with Myelofibrosis Demonstrates Encouraging Outcomes.","publication_year":2025,"publication_date":"2025-02-01","ids":{"openalex":"https://openalex.org/W4407977004","doi":"https://doi.org/10.1016/j.jtct.2025.01.053"},"language":"en","primary_location":{"id":"doi:10.1016/j.jtct.2025.01.053","doi":"https://doi.org/10.1016/j.jtct.2025.01.053","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.053","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.jtct.2025.01.053","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040225749","display_name":"Rachel B. Salit","orcid":"https://orcid.org/0000-0002-4060-9393","observed_orcids":["https://orcid.org/0000-0002-4060-9393"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rachel B. Salit","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kevin Ng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Ng","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116432322","display_name":"Nellie Ratsamee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nellie Ratsamee","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086909430","display_name":"Anna B. Halpern","orcid":"https://orcid.org/0000-0002-4326-0748","observed_orcids":["https://orcid.org/0000-0002-4326-0748"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna B. Halpern","raw_affiliation_strings":["University of Washington School of Medicine, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington School of Medicine, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090982367","display_name":"Raya Mawad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raya Mawad","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081197475","display_name":"Cristina Maria Ghiuzeli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cristina Ghiuzeli","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074629157","display_name":"Bart Lee Scott","orcid":"https://orcid.org/0000-0001-9620-7839","observed_orcids":["https://orcid.org/0000-0001-9620-7839"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bart Scott","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010962133","display_name":"H. Joachim Deeg","orcid":"https://orcid.org/0000-0002-4426-9023","observed_orcids":["https://orcid.org/0000-0002-4426-9023"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Joachim Deeg","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5040225749"],"corresponding_institution_ids":["https://openalex.org/I4210089486"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":0.6492,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.63442583,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":"31","issue":"2","first_page":"S30","last_page":"S31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.8349999785423279,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.8349999785423279,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.1477999985218048,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9419999718666077},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.8849999904632568},{"id":"https://openalex.org/keywords/graft-versus-host-disease-prophylaxis","display_name":"graft-versus-host disease prophylaxis","score":0.949999988079071},{"id":"https://openalex.org/keywords/acute-graft-versus-host-disease","display_name":"acute graft-versus-host disease","score":0.9330000281333923},{"id":"https://openalex.org/keywords/chronic-graft-versus-host-disease","display_name":"chronic graft-versus-host disease","score":0.9539999961853027},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.8799999952316284},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.8119999766349792},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.8880000114440918},{"id":"https://openalex.org/keywords/jak2-mutation","display_name":"JAK2 mutation","score":0.6959999799728394},{"id":"https://openalex.org/keywords/dipss-risk-stratification","display_name":"DIPSS risk stratification","score":0.7039999961853027},{"id":"https://openalex.org/keywords/conditioning-chemotherapy","display_name":"conditioning chemotherapy","score":0.375}],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.9741500616073608},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.924947202205658},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6904531121253967},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.5336993932723999},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.46095967292785645},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44986581802368164},{"id":"https://openalex.org/C2779972918","wikidata":"https://www.wikidata.org/wiki/Q1194520","display_name":"Graft-versus-host disease","level":3,"score":0.4332825541496277},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.43245986104011536},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4275503158569336},{"id":"https://openalex.org/C2779463800","wikidata":"https://www.wikidata.org/wiki/Q5062222","display_name":"Center (category theory)","level":2,"score":0.41286832094192505},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.06411954760551453},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.052177250385284424},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jtct.2025.01.053","doi":"https://doi.org/10.1016/j.jtct.2025.01.053","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.053","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jtct.2025.01.053","doi":"https://doi.org/10.1016/j.jtct.2025.01.053","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.053","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413125035","https://openalex.org/W2919700205","https://openalex.org/W4389246663","https://openalex.org/W3214080626","https://openalex.org/W3020112827","https://openalex.org/W2983690591","https://openalex.org/W4387962125","https://openalex.org/W2804399078","https://openalex.org/W4408765577","https://openalex.org/W4414263650"],"abstract_inverted_index":{"Background":[0],"In":[1,46,205],"the":[2,19,57,64,80,384,457],"last":[3],"decade,":[4],"hematopoietic":[5],"cell":[6],"transplantation":[7],"(HCT)":[8],"outcomes":[9],"in":[10,79,106,346,354,373,381,393,439,467],"patients":[11,109,249,324,360,375,396,402,449,468],"with":[12,36,110,115,153],"myelofibrosis":[13],"(MF)":[14],"have":[15,127,141],"greatly":[16],"improved.":[17],"However,":[18],"incidence":[20,458],"of":[21,59,66,100,119,158,234,303,317,323,383,387,395,420,444,459],"Grade":[22,120],"II-IV":[23,121,343],"acute":[24,69,122,460],"(74%)":[25],"and":[26,48,71,103,112,145,168,176,191,217,225,236,277,292,311,351,425,430,434,461,473,480,491],"all":[27],"grades":[28,352],"chronic":[29,72,406,462],"(52%)":[30],"graft":[31],"versus":[32],"host":[33],"disease":[34],"(GVHD)":[35],"standard":[37,451],"GVHD":[38,70,73,81,209,341,390,407,452,463],"prophylaxis":[39,82,210,453],"is":[40,77],"still":[41],"high":[42,282],"at":[43,128,154,279,326,337,369,397,408,422,454],"our":[44,455],"Center.":[45],"2019":[47],"2021,":[49],"ruxolitinib":[50],"(Rux),":[51],"previously":[52],"only":[53,85],"FDA":[54],"approved":[55,62],"for":[56,63,300,368],"treatment":[58,65],"MF,":[60],"was":[61,181,237,344,366,391,464,478,485],"steroid":[67],"refractory":[68],"respectively.":[74,432],"Whether":[75],"Rux":[76,105,160,180,227,299,365],"useful":[78],"setting":[83],"has":[84],"begun":[86],"to":[87,126,148,162,184,196,207,309,377,448],"be":[88,193,495],"explored.":[89],"Methods":[90],"We":[91],"conducted":[92],"a":[93,116,301,315],"Phase":[94],"II":[95],"single":[96],"center":[97],"prospective":[98],"study":[99,258],"pre-,":[101,471],"peri-,":[102],"post-HCT":[104,200],"HCT":[107],"eligible":[108],"primary":[111,117,264],"secondary":[113],"MF":[114,265],"endpoint":[118],"GVHD.":[123,388],"Patients":[124,150,296],"had":[125,263,271,278,288],"least":[129,155,280,370],"Dynamic":[130],"International":[131],"Prognostic":[132],"Staging":[133],"System":[134],"(DIPSS)":[135],"Intermediate":[136],"I":[137],"stage":[138],"disease,":[139],"not":[140,146],"received":[142,470],"prior":[143,161,308,376],"HCT,":[144],"transformed":[147],"AML.":[149],"were":[151,255,267,297,312,414,436],"treated":[152],"8":[156],"weeks":[157],"planned":[159],"conditioning":[163,294,310],"chemotherapy":[164],"(cyclophosphamide":[165],"120":[166],"mg/kg":[167],"targeted":[169],"4-day":[170],"busulfan,":[171],"or":[172,273],"fludarabine":[173],"150":[174],"mg/m2,":[175],"melphalan":[177],"140":[178],"mg/m2).":[179],"then":[182],"tapered":[183,238],"5mg":[185],"BID":[186,198],"by":[187,239],"Day":[188,201,328,338],"-4":[189],"pre-HCT":[190],"could":[192],"increased":[194],"up":[195],"10mg":[197],"after":[199,232],"+28":[202],"if":[203],"tolerated.":[204],"addition":[206],"Rux,":[208],"included":[211],"tacrolimus":[212,235],"(tac)":[213],"(target":[214],"level":[215],"5-10)":[216],"MTX":[218],"10mg/m2":[219],"on":[220,257,298],"Days":[221],"1,":[222],"3,":[223],"6":[224,304],"11;":[226],"taper":[228],"started":[229],"1":[230,281,371,398,410,423],"month":[231,240],"completion":[233],"9":[241,385],"-":[242],"12":[243,318],"per":[244],"clinician":[245],"discretion.":[246],"Results":[247],"Twenty-five":[248],"median":[250,302,316,327],"age":[251],"66":[252],"(range":[253,305,330],"42-71)":[254],"enrolled":[256],"between":[259],"2020-2024.":[260],"The":[261],"majority":[262],"(60%),":[266],"JAK2":[268],"mutated":[269],"(68%),":[270],"intermediate-2":[272],"high-risk":[274],"DIPSS":[275],"(72%)":[276],"molecular":[283],"risk":[284],"mutation":[285],"(54%).":[286],"Most":[287],"unrelated":[289],"donors":[290],"(76%)":[291],"fludarabine/melphalan":[293],"(68%).":[295],"2-24)":[306],"months":[307,320],"continued":[313],"until":[314],"(3-34)":[319],"post-HCT.":[321],"96%":[322],"engrafted":[325,336],"20":[329],"15":[331],"\u2013":[332],"26);":[333],"one":[334],"patient":[335],"43.":[339],"Acute":[340],"grade":[342],"diagnosed":[345],"36%":[347],"(n":[348,356,441],"=":[349,357,442],"9),":[350],"III-IV":[353],"8%":[355,440],"2);":[358],"2":[359,382,400,426],"required":[361],"topical":[362],"therapy":[363],"only.":[364],"held":[367],"week":[372],"3":[374],"day":[378],"100":[379],"resulting":[380],"cases":[386],"Chronic":[389],"seen":[392,438],"12%":[394],"year;":[399],"additional":[401],"developed":[403],"de":[404],"novo":[405],">":[409],"year":[411,424,482],"once":[412],"they":[413],"off":[415],"Rux.":[416,475],"Kaplan":[417],"Meier":[418],"estimates":[419],"survival":[421,484],"years":[427],"are":[428,489],"100%":[429],"87%":[431],"Relapse":[433],"NRM":[435],"each":[437],"2)":[443],"patients.":[445],"Conclusions":[446],"Compared":[447],"given":[450],"Center,":[456],"considerably":[465],"reduced":[466],"who":[469],"peri-":[472],"post-transplant":[474],"Non-relapse":[476],"mortality":[477],"low":[479],"1-":[481],"overall":[483],"100%.":[486],"These":[487],"data":[488],"encouraging,":[490],"this":[492],"strategy":[493],"will":[494],"further":[496],"pursued.":[497]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-02-27T00:00:00"}